Gayla Zoghlin
Family Medicine · Novi, MINPI 1417924549
Payments from drug & device makers
Across 142 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$351
- Amgen$335
- Johnson & Johnson$233
- Boehringer Ingelheim$142
- GSK$133
- Pfizer$118
- plus $859 from 17 others
What the payments were for
- Food & beverage$2,171100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $351 |
| Amgen | 22 | $335 |
| Johnson & Johnson | 18 | $233 |
| Boehringer Ingelheim | 9 | $142 |
| GSK | 7 | $133 |
| Pfizer | 8 | $118 |
| Amarin Pharma, Inc. | 9 | $115 |
| Novo Nordisk | 7 | $113 |
| Lilly USA, LLC | 6 | $81 |
| Merck | 6 | $77 |
| Teva Pharmaceuticals USA, Inc. | 5 | $69 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| AbbVie | 2 | $52 |
| Dexcom, Inc. | 3 | $46 |
| Sanofi Pasteur Inc. | 2 | $43 |
| Dynavax Technologies Corporation | 3 | $38 |
| Cranial Technologies, Inc | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Olympus America Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Shire North American Group Inc | 1 | $19 |
| Novartis | 1 | $15 |
How this compares
$2,171 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 19 | $26,957 |
| OzempicSemaglutide | 16 | $18,300 |
| JardianceEmpagliflozin | 22 | $18,186 |
| Levothyroxine Sodium | 122 | $1,774 |
| Atorvastatin Calcium | 167 | $1,679 |
| Metoprolol Succinate | 50 | $948 |
| Losartan Potassium | 67 | $903 |
| Ibandronate Sodium | 21 | $844 |
| Omeprazole | 81 | $795 |
| Famotidine | 51 | $673 |
| Bupropion XlBupropion Hcl | 35 | $646 |
| Escitalopram Oxalate | 23 | $575 |
| Pantoprazole Sodium | 29 | $520 |
| Simvastatin | 60 | $510 |
| Metformin Hcl ErMetformin Hcl | 21 | $435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $77 | $26,95719 claims |
| Novo NordiskOzempic | $113 | $18,30016 claims |
| Boehringer IngelheimJardiance | $142 | $18,18622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Novi
- Marshall SackNovi$53K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.